Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-050684
Filing Date
2022-04-27
Accepted
2022-04-27 08:00:42
Documents
4
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223678-1_def14a.htm DEF 14A 704729
2 GRAPHIC sg_jillmilne-bw.jpg GRAPHIC 7184
3 GRAPHIC tm223678d1-pxy_proxy1bw.jpg GRAPHIC 991841
4 GRAPHIC tm223678d1-pxy_proxy2bw.jpg GRAPHIC 1123935
  Complete submission text file 0001104659-22-050684.txt   3625703
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 22856409
SIC: 2834 Pharmaceutical Preparations